Showing BioInteractions for Pyrantel (DB11156)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Pyrantel is a Cytochrome P450 4A11 substrate | ||
| 1 | Cytochrome P450 4A11 substrates | Clofibrate, Lusutrombopag, Pentamidine, Plitidepsin, Polyethylene glycol 400, Tretinoin |
| 2 | Cytochrome P450 4A11 inducers | Cisplatin, Clofibrate, Dexamethasone, Dexamethasone acetate, Ethanol, Tildrakizumab |
| 3 | Cytochrome P450 4A11 inhibitors | Pegvisomant |